A Postmarket Clinical Trial for EXCROSSAL Stent in CAD Patients With 3-month DAPT or 12-month DAPT

Inclusion Criteria: 1. Age ≥18 years and ≤75 years; 2. De novo coronary artery primary lesions; 3. Stable angina pectoris; 4. Patients with coronary artery disease with similar symptoms of myocardial ischemia or angina; 5. Suitable for PCI indication and suitable for the implant of EXCROSSAL stents. 6. Able to understand the purpose of the study, voluntarily participate and sign the informed consent form, and willing to accept the clinical follow-up; Imaging criteria The target lesion length≤ 60mm；Visual reference diameter of the vessel is 2.25-4.0mm; Exclusion Criteria: 1. Patients with acute myocardial infarction (AMI) within 7 days; Non-ST elevated ACS patients 2. those who implanted any stent before; 3. Left ventricular ejection score(LVEF) 30 % 4. Patients with bleeding tendency or anticoagulation treatment contraindications and/or PCI contraindications or coagulopathy; 5. There are other diseases such as cancer, malignant tumor, congestive heart failure, organ transplant, or candidate) or has a history of abuse (alcohol, cocaine, heroin, etc.), plan adherence is poor, or the life expectancy of less than 1 year; 6. It is estimated that elective surgery patients within 12 months; 7. Other coronary lesions requiring staged intervention; 8. If there are branches of blood vessels that need to be treated, the diameter of blood vessels ≥ 2.5 mm; 9. The subject's compliance or the researcher's judgment was not suitable for the participants in the study; 10. Pregnant or lactating persons; Imaging criteria 1\. Left main disease, transplanted vessel lesions, stent restenosis; 2. The balloon cannot be predilated or/or the severe calcification lesion of rotatory failure; 3. The distortion of the stent is difficult to pass;